CYTR Overview
Upcoming Projects (CYTR)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CYTR)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (CYTR)
-
What Should We Expect from CytRx Phase 3 Data for Aldoxorubicin in Soft Tissue Sarcoma Coming July 2016?
Ticker: CYTR
Execute By: Sep 30, 2016
Upcoming & Overdue Catalysts (CYTR)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CYTR)
-
CytRx (CYTR) Highlights Use of Aldoxorubicin in Phase 2 Clinical Trials on Survival Rates in Metastatic Pancreatic Cancer Patients
Ticker: CYTR
Occurred on: Jan 15, 2021 -
Phase 2b data of Aldoxorubicin for relapsed/refractory small cell lung cancer due Q1 2017
Ticker: CYTR
Occurred on: Aug 03, 2017 -
FDA Approves CytRx's (CYTR) Plan to Submit a Rolling New Drug Application (NDA) for Aldoxorubicin in Soft Tissue Sarcoma (STS)
Ticker: CYTR
Occurred on: Apr 19, 2017 -
CytRx (CYTR) Reports Updated Results from Pivotal Phase 3 Trial of Aldoxorubicin in Patients with Second-Line Soft Tissue Sarcomas
Ticker: CYTR
Occurred on: Nov 29, 2016 -
Interim Results from On-going Aldoxorubicin Plus Ifosfamide/Mesna Combination Clinical Trial Presented at ESMO 2016 Congress
Ticker: CYTR
Occurred on: Oct 10, 2016 -
CytRx Corporation Announces Pricing of $20 Million Public Offering of Common Stock and Warrants
Ticker: CYTR
Occurred on: Jul 15, 2016 -
CytRx Expects Phase 3 Data for Aldoxorubicin in Soft Tissue Sarcoma July 2016
Ticker: CYTR
Occurred on: Jul 11, 2016 -
CytRx Secures $40 Million Long-Term Loan Facility
Ticker: CYTR
Occurred on: Feb 08, 2016
Strategic Initiatives (CYTR)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
